Charles River Laboratories Intl. Inc vs M&T Bank Corporation — how do they compare? Charles River Laboratories Intl. Inc trades at $287.99 (market cap $13.46B), while M&T Bank Corporation trades at $251.93 (market cap $36.42B). The key difference: M&T Bank Corporation is far larger — about 2.7× Charles River Laboratories Intl. Inc's market cap, and M&T Bank Corporation pays a 2.38% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CRL | MTB | |
|---|---|---|
Market Cap | $13.46B | $36.42B |
Sector | Health | Financials |
52-Week High | $282.00 | $254.04 |
52-Week Low | $145.57 | $178.63 |
Enterprise Value | $16.30B | — |
Dividend Yield | — | 2.38% |
Trailing returns across standard periods
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →